These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6659545)

  • 21. Hepatic clearance of gitoxin. Metabolism and biliary excretion by rabbit isolated liver.
    Pellegrin PL; Lesne M
    Drug Metab Dispos; 1984; 12(2):235-41. PubMed ID: 6144490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural characterization of urinary metabolites of the antiarrhythmic drug encainide in human subjects.
    Jajoo HK; Mayol RF; LaBudde JA; Blair IA
    Drug Metab Dispos; 1990; 18(1):28-35. PubMed ID: 1970774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of etoposide glucuronide as a major metabolite of etoposide in the rat and rabbit.
    Hande K; Anthony L; Hamilton R; Bennett R; Sweetman B; Branch R
    Cancer Res; 1988 Apr; 48(7):1829-34. PubMed ID: 3349461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the biliary and urinary glutathione and N-acetylcysteine metabolites of the hepatic carcinogen 1'-hydroxysafrole and its 1'-oxo metabolite in rats and mice.
    Fennell TR; Miller JA; Miller EC
    Cancer Res; 1984 Aug; 44(8):3231-40. PubMed ID: 6744260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism and excretion of atorvastatin in rats and dogs.
    Black AE; Hayes RN; Roth BD; Woo P; Woolf TF
    Drug Metab Dispos; 1999 Aug; 27(8):916-23. PubMed ID: 10421619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of dilevalol and its conjugates in man. Assay method for plasma, blood, urine and bile samples and preliminary pharmacokinetic studies.
    Neubeck M; Becker C; Henke D; Rösch W; Spahn-Langguth H; Mutschler E
    Arzneimittelforschung; 1993 Sep; 43(9):953-7. PubMed ID: 8240457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of catechol oestrogen from oxidation during enzymic hydrolysis of biliary conjugates.
    Maggs JL; Grabowski PS; Park BK
    J Steroid Biochem; 1983 Aug; 19(2):1235-7. PubMed ID: 6310265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-protein conjugates--V. Sex-linked differences in the metabolism and irreversible binding of 17 alpha-ethinylestradiol in the rat.
    Maggs JL; Grabowski PS; Park BK
    Biochem Pharmacol; 1983 Sep; 32(18):2793-800. PubMed ID: 6626249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.
    Heggie GD; Sommadossi JP; Cross DS; Huster WJ; Diasio RB
    Cancer Res; 1987 Apr; 47(8):2203-6. PubMed ID: 3829006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of the anti-tumour drugs N2-methyl-9-hydroxyellipticinium acetate (NSC 264137) and N2-methyl-9-hydroxyolivacinium acetate in the rat: preliminary identification of biliary 9-(O)-glucuronide and 10-(S)-glutathione conjugates.
    Maftouh M; Meunier G; Dugue B; Monsarrat B; Meunier B; Paoletti C
    Xenobiotica; 1983 May; 13(5):303-10. PubMed ID: 6636827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of 3-phenoxybenzoic acid and the enterohepatorenal disposition of its metabolites in the rat.
    Huckle KR; Chipman JK; Hutson DH; Millburn P
    Drug Metab Dispos; 1981; 9(4):360-8. PubMed ID: 6114836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired biliary elimination of beta-glucuronidase-resistant "glucuronides" of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers.
    Dickinson RG; Kluck RM; Wood BT; Eadie MJ; Hooper WD
    Drug Metab Dispos; 1986; 14(2):255-62. PubMed ID: 2870903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism and biliary excretion of 2,4,5,2',4',5'-hexachlorobiphenyl in the rhesus monkey (Macaca mulatta).
    Norback DH; Mack E; Reddy G; Britt J; Hsia MT
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):71-85. PubMed ID: 6794118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatotoxic effects of estradiol-17 beta-D-glucuronide in the rat and monkey.
    Slikker W; Vore M; Bailey JR; Meyers M; Montgomery C
    J Pharmacol Exp Ther; 1983 Apr; 225(1):138-43. PubMed ID: 6300372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metabolism of 2- and 4-fluoro-17 beta-oestradiol in the rat and its implications for oestrogen carcinogenesis.
    Morgan P; Maggs JL; Bulman-Page PC; Hussain F; Park BK
    Biochem Pharmacol; 1992 Mar; 43(5):985-93. PubMed ID: 1554397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biliary excretion of radioactivity after intravenous administration of 3H-1,25-dihydroxyvitamin D3 in man.
    Ledger JE; Watson GJ; Ainley CC; Compston JE
    Gut; 1985 Nov; 26(11):1240-5. PubMed ID: 3840765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biliary excretion of radioactivity after intravenous administration of [3H]25-hydroxyvitamin D3 in man.
    Ledger JE; Watson GJ; Compston JE
    Dig Dis Sci; 1986 Apr; 31(4):361-8. PubMed ID: 3956332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conjugated forms of [3H] alpha, 25-dihydroxyvitamin D3 in rat bile.
    Ayton B; Martin F
    J Steroid Biochem; 1987 Jun; 26(6):667-77. PubMed ID: 3039252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of 17alpha-ethynylestradiol by intact liver parenchymal cells isolated from mouse and rat.
    Helton ED; Casciano DA; Althaus ZR; Plant HD
    J Toxicol Environ Health; 1977 Dec; 3(5-6):953-63. PubMed ID: 599590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.